Catalyst Wire Dossier Catalyst Wire Dossier

CBD/PEA sublingual formulation (water-soluble CBD/PEA)

· Pure Green Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CBD/PEA sublingual formulation (water-soluble CBD/PEA), covering 2023-03-13 to 2023-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA [Phase 1, Phase 2]

See pricing